We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+7.67%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$22.4B
AUM Growth
+$4.58B
(+26%)
Cap. Flow
+$3.46B
Cap. Flow
% of AUM
15.44%
Top 10 Holdings %
Top 10 Hldgs %
18.61%
Holding
1,174
New
365
Increased
222
Reduced
249
Closed
328
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$455M |
| 2 |
AABA
Altaba Inc
AABA
|
+$237M |
| 3 |
Amazon
AMZN
|
+$185M |
| 4 |
DuPont de Nemours
DD
|
+$162M |
| 5 |
Danaher
DHR
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$158M |
| 2 |
JD.com
JD
|
+$125M |
| 3 |
Biogen
BIIB
|
+$114M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$110M |
| 5 |
Mastercard
MA
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.38% |
| 2 | Consumer Discretionary | 10.54% |
| 3 | Energy | 8.23% |
| 4 | Industrials | 8.1% |
| 5 | Communication Services | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Adobe
ADBE
$89.5B
| – | – |
-30,000
| Closed | -$4.24M |
|
|
ADAP
852
DELISTED
Adaptimmune Therapeutics
ADAP
| – | – |
-545,500
| Closed | -$2.45M |
|
853
CALL
Adeia
ADEA
$2.86B
| – | – |
-761,292
| Closed | -$6M |
|
854
American Financial Group
AFG
$11.9B
| – | – |
-100,600
| Closed | -$10M |
|
855
American International
AIG
$41.9B
| – | – |
-76,000
| Closed | -$4.75M |
|
856
Albemarle
ALB
$13.5B
| – | – |
-15,000
| Closed | -$1.58M |
|
857
Alkermes
ALKS
$8.82B
| – | – |
-96,000
| Closed | -$5.57M |
|
858
Applied Materials
AMAT
$426B
| – | – |
-68,600
| Closed | -$2.83M |
|
859
AMC Entertainment Holdings
AMC
$2.03B
| – | – |
-7,220
| Closed | -$1.64M |
|
|
AMED
860
PUT
DELISTED
Amedisys
AMED
| – | – |
-200,000
| Closed | -$12.6M |
|
861
PUT
Alerian MLP ETF
AMLP
$13B
| – | – |
-60,000
| Closed | -$3.59M |
|
862
Amphastar Pharmaceuticals
AMPH
$825M
| – | – |
-175,000
| Closed | -$3.13M |
|
|
AMRN
863
Amarin Corp
AMRN
$284M
| – | – |
-36,260
| Closed | -$2.92M |
|
864
PUT
AutoNation
AN
$6.97B
| – | – |
-50,000
| Closed | -$2.11M |
|
|
ANSS
865
DELISTED
Ansys
ANSS
| – | – |
-6,700
| Closed | -$815K |
|
866
Appian
APPN
$1.74B
| – | – |
-10,233
| Closed | -$186K |
|
867
AptarGroup
ATR
$8.45B
| – | – |
-15,100
| Closed | -$1.31M |
|
|
OPTU
868
Optimum Communications Inc
OPTU
$316M
| – | – |
-259,009
| Closed | -$8.37M |
|
869
Avanos Medical
AVNS
$1.17B
| – | – |
-12,700
| Closed | -$499K |
|
|
DCH
870
PUT
Dauch Corp
DCH
$1.3B
| – | – |
-100,000
| Closed | -$1.56M |
|
871
American Express
AXP
$223B
| – | – |
-335,664
| Closed | -$28.3M |
|
872
Axalta
AXTA
$7.01B
| – | – |
-417,622
| Closed | -$13.4M |
|
873
Azenta
AZTA
$1.26B
| – | – |
-351,900
| Closed | -$7.63M |
|
874
PUT
Bank of America
BAC
$435B
| – | – |
-800,000
| Closed | -$19.4M |
|
875
Brunswick
BC
$5.19B
| – | – |
-367,800
| Closed | -$23.1M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, Point72 Asset Management held 1,174 positions worth $22.4B, up 26% from $17.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Point72 Asset Management deployed $3.46B of net new capital in Q3 2017, opening 365 new positions and adding to 222 existing holdings. Its largest new stake was Nebius Group N.V.: 3,618,469 shares worth $119M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Visa, an estimated $158M trimmed.
- Point72 Asset Management's largest Q3 2017 buy was Nebius Group N.V.: 3,618,469 shares worth $119M.
- Point72 Asset Management added most to Time Warner Inc in Q3 2017, an estimated $455M increase.
- Point72 Asset Management's biggest Q3 2017 reduction was Visa, cutting an estimated $158M.
- Point72 Asset Management fully exited Gilead Sciences in Q3 2017, selling an estimated $90.1M.
- Point72 Asset Management's ten largest holdings make up 19% of its $22.4B portfolio in Q3 2017.
- Point72 Asset Management opened 365 new positions and closed 328 in Q3 2017.
- Point72 Asset Management's portfolio value rose 26% quarter-over-quarter to $22.4B.
Based on Point72 Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.